Literature DB >> 23995891

Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.

K S Alexander1, M R Kothapalli, D Dollimor.   

Abstract

The stability of 40 micrograms/mL extemporaneously formulated syrup from commercially available levothyroxine sodium tablets, using sorbitol 70% as the diluting vehicle, was studied. The concentration of levothyroxine sodium in the formulation was 40 micrograms/mL. The protocol included accelerated stability testing at temperatures of 40 deg, 50 deg, 60 deg, and 70 deg C and a high-performance liquid chromatography assay procedure using testosterone propionate as the internal standard. The data were analyzed using an Arrhenius plot to determine the shelf-life of formulation. The shelf-life was found to be approximately 15 days at 25 deg C and 47 days at 5 deg C.

Entities:  

Year:  1997        PMID: 23995891

Source DB:  PubMed          Journal:  Int J Pharm Compd        ISSN: 1092-4221


  2 in total

1.  Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization.

Authors:  E Rostami; S Kashanian; A H Azandaryani
Journal:  Mol Biol Rep       Date:  2014-02-11       Impact factor: 2.316

Review 2.  Improving policies and practices for the extemporaneous compounding of oral liquid dosage forms in Saudi Arabian hospitals.

Authors:  Imraan Joosub; Zohair Emara; Andy Gray
Journal:  Eur J Hosp Pharm       Date:  2019-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.